Little Rock, ARKANSAS4 Active Studies

Multiple Myeloma Clinical Trials in Little Rock, ARKANSAS

Find 4 actively recruiting multiple myeloma clinical trials in Little Rock, ARKANSAS. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,825
Enrolling

Recruiting Multiple Myeloma Studies in Little Rock

RecruitingLittle Rock, ARKANSASNCT05535946

ABTECT - Maintenance

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...

1,050 participants
Abivax S.A.
View Study Details
RecruitingLittle Rock, ARKANSASNCT04634552

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the efficacy and safety of talquetamab in participants with relapsed or refractory multiple myeloma at the recommended Phase 2 dose(s) (RP2Ds) (Part 3)....

510 participants
Janssen Research & Development, LLC
View Study Details
RecruitingLittle Rock, ARKANSASNCT06297226

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple myeloma....

175 participants
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
View Study Details
RecruitingLittle Rock, ARKANSASNCT07113522

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the saf...

90 participants
Mirador Therapeutics, Inc.
View Study Details

About Multiple Myeloma Clinical Trials in Little Rock

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 4 multiple myeloma clinical trials recruiting participants in Little Rock, ARKANSAS. These studies are seeking a combined 1,825 participants. Research is being sponsored by Abivax S.A., Janssen Research & Development, LLC, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Little Rock — FAQ

Are there multiple myeloma clinical trials in Little Rock?

Yes, there are 4 multiple myeloma clinical trials currently recruiting in Little Rock, ARKANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.

Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 4 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated March 2, 2026 from ClinicalTrials.gov